retatrutide phase 2 trial type 2 diabetes weight loss 2024 Retatrutide, a TRIPLE agonist (GLP1, GIP, glucagon), just released results demonstrating 25% in half of people with #obesity. This amount of weight loss has not been accomplished Effects of retatrutide on body

Communication is text-based through their platform

Retatrutides effectiveness in both adipose tissue reduction and glycemic control suggests it could be a game-changing therapy for type 2 diabetes and obesity management (McPherson et al., 2023)

..I wrote one-third of the LessWrong posts I've ever written in the last month [3]

No need to step through the lower doses again.It's a straightforward switch and for many, probably a welcome one.The MHRA's approval marks the first time a GLP-1 tablet of this kind has been cleared for use in the UK, and it signals a broader shift in how weight management treatment might look in the years ahead

Over the counter antihistamines like diphenhydramine (Benadryl) or cetirizine (Zyrtec) can reduce itching and minor allergic type reactions at injection sites